Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HNF4A | P41235 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.36 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | TTR | P02766 | 1/20 | 0.35 |
| ▸ | FABP4 | P15090 | 1/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30166530 | 0.86 | TSHR (0.41) | HNF4AHDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL392931 | 0.86 | TSHR (0.41) | HNF4AHDAC4HDAC2HDAC8HDAC6 | |
| Hydrochloric Acid SCHEMBL11760140 | 0.84 | PTGS2 (0.40) | HNF4AHDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL21794264 | 0.80 | TSHR (0.46) | HNF4AHDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL27690669 | 0.80 | STAT3 (0.44) | BCAT2PTGS2CDK2ALDH1A1HPGD | |
| Urea SCHEMBL4970936 | 0.80 | BCAT2 (0.46) | HNF4ABCAT2DAPK1CASP1PTGS2 | |
| SCHEMBL2731656 | 0.80 | CASP1 (0.37) | HNF4AHDAC4HDAC2HDAC8HDAC6 | |
| Ether SCHEMBL2731657 | 0.78 | PTGS2 (0.37) | CASP1PTGS2TTRFABP4CCNA2 | |
| Phthalic Acid SCHEMBL8745684 | 0.77 | HNF4A (0.53) | HNF4ABCAT2CYP2D6FABP4TSHR | |
| (Z)-1,2-Diphenylethene SCHEMBL28265888 | 0.77 | PTPN1 (0.44) | HDAC4HDAC2HDAC8HDAC6CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060193789-A1 | Surfacant, film forming agent, water, gas propellant; plant and animal extracts and oils; may include malathion | FOAMIX LTD. (IL) | 2006-08-31 | — | — | US | claimed |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | disclosed |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | CoLabs International Corporation (US) | 2023-12-12 | — | — | US | disclosed |
| US-11752086-B2 | Topical formulations and methods | MYOCEPT INC. (US) | 2023-09-12 | — | — | US | disclosed |
| US-11724134-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CoLabs International Corporation (US) | 2023-08-15 | — | — | US | disclosed |
| EP-3813786-A1 | COMPOSITIONS COMPRISING SILICON DIOXIDE-BASED PARTICLES INCLUDING ONE OR MORE AGENTS | Colabs International Corporation (US) | 2021-05-05 | — | — | EP | disclosed |
| US-10889753-B2 | Self-breakable treatment fluids for use in subterranean formation operations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2021-01-12 | — | — | US | disclosed |
| US-20190290940-A1 | Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent | CoLabs International Corporation (US) | 2019-09-26 | — | — | US | disclosed |
| US-10322301-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CoLabs International Corporation (US) | 2019-06-18 | — | — | US | disclosed |
| US-20190127629-A1 | SELF-BREAKABLE TREATMENT FLUIDS FOR USE IN SUBTERRANEAN FORMATION OPERATIONS | HALLIBURTON ENERGY SERVICES, INC. | 2019-05-02 | — | — | US | disclosed |
| US-20060093636-A1 | Comprises allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; composition is in the form of an oil-in-water emulsion; pH of the composition is about 3.0 to 6.0; preferred acidic anionic polymer is a carboxypolymethylene polymer; stability | ALWYN COMPANY, INC. (US) | 2006-05-04 | — | — | US | disclosed |
| US-20060067959-A1 | Compositions and methods for treatment of solar damage | NIMNI MARCEL | 2006-03-30 | — | — | US | disclosed |
| US-20060045926-A1 | Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin | NIMNI MARCEL | 2006-03-02 | — | — | US | disclosed |
| WO-2003070161-A2 | EMULSIFIED SKIN CARE COMPOSITION CONTAINING SALICYLIC ACID, LANOLIN OIL, AND PROPYLENE GLYCOL | ALWYN COMPANY, INC. (US) | 2003-08-28 | — | — | WO | disclosed |
| US-20030157137-A1 | Emulsified skin care composition containing salicylic acid, lanolin oil, and propylene glycol | ALWYN COMPANY, INC. | 2003-08-21 | — | — | US | disclosed |
| US-20030147968-A1 | Allantoin-containing preparations for administration as gels and aerosols | ALWYN COMPANY, INC. | 2003-08-07 | — | — | US | disclosed |
| WO-2003053369-A1 | ALLANTOIN-CONTAINING PREPARATIONS FOR ADMINISTRATION AS GELS AND AEROSOLS | ALWYN COMPANY, INC. (US) | 2003-07-03 | — | — | WO | disclosed |
| US-20020054895-A1 | And at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; skin protectants | ALWYN COMPANY, INC. | 2002-05-09 | — | — | US | disclosed |
| US-6376557-B1 | TRANSDERMAL SUPPLYING | ZAVERI CHANDA BHUWALKA (US) | 2002-04-23 | — | — | US | disclosed |
| WO-2001068107-A1 | HAIR RESTORATION FORMULATION | ZAVERI CHANDA BHUWALKA (US) | 2001-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11724134-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CUTA, ACMSD, TYR | HNF4A 4375/4885HDAC4 561/4885HDAC2 1500/4885 |
| US-20060045926-A1 | Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin | COL1A1, COL14A1, COL2A1 | HNF4A 2102/4885HDAC4 3666/4885HDAC2 4336/4885 |
| US-20190290940-A1 | Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent | CUTA, ACMSD, TYR | HNF4A 4375/4885HDAC4 561/4885HDAC2 1500/4885 |
| US-11752086-B2 | Topical formulations and methods | KRT18, ANXA3, VIP | HNF4A 2498/4885HDAC4 2254/4885HDAC2 4372/4885 |
| US-10322301-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CUTA, ACMSD, TYR | HNF4A 4375/4885HDAC4 561/4885HDAC2 1500/4885 |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | MSN, LIPE, CUTA | HNF4A 4473/4885HDAC4 1891/4885HDAC2 3227/4885 |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | MSN, LIPE, CUTA | HNF4A 4489/4885HDAC4 1967/4885HDAC2 3302/4885 |
| US-20060067959-A1 | Compositions and methods for treatment of solar damage | AAAS, LRRK2, CSTB | HNF4A 4606/4885HDAC4 4506/4885HDAC2 3557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.